556 related articles for article (PubMed ID: 25865094)
41. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
Fan B; Guan J; Wang X; Cong Y
PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107
[TBL] [Abstract][Full Text] [Related]
42. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
Kengkla K; Kongpakwattana K; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
J Antimicrob Chemother; 2018 Jan; 73(1):22-32. PubMed ID: 29069421
[TBL] [Abstract][Full Text] [Related]
43. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
44. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
[TBL] [Abstract][Full Text] [Related]
45. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
[TBL] [Abstract][Full Text] [Related]
46. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Amat T; Gutiérrez-Pizarraya A; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Torre-Giménez Á; Garnacho-Montero J; Cisneros JM; Torre-Cisneros J
Clin Microbiol Infect; 2018 Jun; 24(6):630-634. PubMed ID: 28970161
[TBL] [Abstract][Full Text] [Related]
47. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
Marie MA; Krishnappa LG; Alzahrani AJ; Mubaraki MA; Alyousef AA
Bosn J Basic Med Sci; 2015 Oct; 15(4):24-9. PubMed ID: 26614848
[TBL] [Abstract][Full Text] [Related]
48. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
Schafer JJ; Goff DA; Stevenson KB; Mangino JE
Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
[TBL] [Abstract][Full Text] [Related]
49. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Ozbek B; Sentürk A
Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
[TBL] [Abstract][Full Text] [Related]
50. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
51. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
53. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
[TBL] [Abstract][Full Text] [Related]
54. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
55. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
[TBL] [Abstract][Full Text] [Related]
56. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
Lee YT; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Yang YS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674056
[TBL] [Abstract][Full Text] [Related]
57. Carbapenem-resistant Acinetobacter baumannii mediastinitis after aortic graft implantation successfully treated by adjunctive gentian violet irrigation and antibiotic combination therapy.
Li SJ; Chang CW; Chen FL; Ou TY; Lee WS
J Microbiol Immunol Infect; 2016 Dec; 49(6):977-979. PubMed ID: 27553449
[No Abstract] [Full Text] [Related]
58. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
Lee CH; Tang YF; Su LH; Chien CC; Liu JW
Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
[TBL] [Abstract][Full Text] [Related]
60. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]